Healthcare provider profile · identity verified

Ilsa Annetta Shulman, MD

Internal Medicine · BANGOR, ME · NPI 1023082674

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	398	113
Levothyroxine Sodium	Levothyroxine Sodium	353	94
Lisinopril	Lisinopril	233	67
Hydrochlorothiazide	Hydrochlorothiazide	182	53
Amlodipine Besylate	Amlodipine Besylate	174	53
Losartan Potassium	Losartan Potassium	166	45
Rosuvastatin Calcium	Rosuvastatin Calcium	160	44
Gabapentin	Gabapentin	148	44
Simvastatin	Simvastatin	131	40
Metoprolol Succinate	Metoprolol Succinate	122	38
Metoprolol Tartrate	Metoprolol Tartrate	120	33
Omeprazole	Omeprazole	114	39
Pantoprazole Sodium	Pantoprazole Sodium	103	32
Trazodone Hcl	Trazodone Hcl	94	30
Metformin Hcl	Metformin Hcl	86	26
Tramadol Hcl	Tramadol Hcl	72	26
Potassium Chloride	Potassium Chloride	71	25
Alendronate Sodium	Alendronate Sodium	70	21
Eliquis	Apixaban	64	17
Albuterol Sulfate Hfa	Albuterol Sulfate	60	37
Escitalopram Oxalate	Escitalopram Oxalate	60	20
Sertraline Hcl	Sertraline Hcl	58	17
Allopurinol	Allopurinol	54	15
Pravastatin Sodium	Pravastatin Sodium	54	16
Carvedilol	Carvedilol	52	11
Tamsulosin Hcl	Tamsulosin Hcl	51	16
Duloxetine Hcl	Duloxetine Hcl	45	12
Atenolol	Atenolol	42	12
Arexvy	Rsvpref3 Antigen/As01e/Pf	39	39
Citalopram Hbr	Citalopram Hydrobromide	38	12
Furosemide	Furosemide	38	19
Metformin Hcl Er	Metformin Hcl	37	12
Synthroid	Levothyroxine Sodium	37	11
Lovastatin	Lovastatin	36	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	36	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	16
Valsartan	Valsartan	34	11
Fluticasone Propionate	Fluticasone Propionate	33	12
Finasteride	Finasteride	32	suppressed
Pregabalin	Pregabalin	32	16
Tizanidine Hcl	Tizanidine Hcl	32	13
Isosorbide Mononitrate Er	Isosorbide Mononitrate	31	11
Ozempic	Semaglutide	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Celecoxib	Celecoxib	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Famotidine	Famotidine	27	11
Ezetimibe	Ezetimibe	25	suppressed
Oxycodone Hcl	Oxycodone Hcl	25	13
Mirtazapine	Mirtazapine	23	suppressed
Montelukast Sodium	Montelukast Sodium	23	suppressed
Nitroglycerin	Nitroglycerin	23	13
Trulicity	Dulaglutide	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Glipizide	Glipizide	21	suppressed
Hydralazine Hcl	Hydralazine Hcl	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Clopidogrel	Clopidogrel Bisulfate	18	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	18	17
Amoxicillin	Amoxicillin	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	17	suppressed
Alprazolam	Alprazolam	16	11
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	12
Memantine Hcl Er	Memantine Hcl	13	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Prednisone	Prednisone	11	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error